Mac Keon, S., Bentivegna, S., Levy, E. M., Marks, M. S., Mantegazza, A. R., Wainstok, R., & Mordoh, J. (2019). Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model. Web
Citación estilo ChicagoMac Keon, Soledad, Sofía Bentivegna, Estrella Mariel Levy, Michael S. Marks, Adriana Rita Mantegazza, Rosa Wainstok, and Jose Mordoh. Syngeneic B16-F1 Cells Are More Efficient Than Allogeneic Cloudman Cells As Antigen Source in DC-based Vaccination in the B16-F1 Murine Melanoma Model. 2019.
Cita MLAMac Keon, Soledad, et al. Syngeneic B16-F1 Cells Are More Efficient Than Allogeneic Cloudman Cells As Antigen Source in DC-based Vaccination in the B16-F1 Murine Melanoma Model. 2019.